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Sutureless valves were designed in an attempt to simplify the aortic valve replacement procedure and reduce 
extracorporeal circuit time, whilst allowing complete excision of the calcified native valve using a minimal-
ly invasive approach. Elderly patients with significant comorbidities are considered to benefit the most, al-
though randomized data are lacking. In registries of patients treated with implantation of a 3f Enable suture-
less bioprosthetic aortic valve, all patients who developed paravalvular leak have been treated with valve ex-
plantation. This is the first case report describing a tricky yet successful percutaneous paravalvular leak clo-
sure 2 years after implantation of a 3f Enable sutureless aortic bioprosthesis.
S utureless valves were designed in an attempt to simplify the aortic valve replacement procedure and 
reduce extracorporeal circuit time, whilst 
allowing complete excision of the calcified 
native valve using a minimally invasive ap-
proach (right anterior mini-thoracotomy). 
Elderly patients with significant comorbid-
ities are considered to benefit the most, 
even though randomized data are lacking. 
In a registry of 140 patients with aortic 
stenosis1 who were treated with the 3f En-
able valve (Medtronic Inc., Minneapolis, 
USA) there were 4 cases with major para-
valvular leaks (PVL), 3 early and one late, 
all of which resulted in valve explantation. 
In the current case report we describe for 
the first time a tricky yet successful percu-
taneous paravalvular leak closure 2 years 
after the implantation of a 3f Enable su-
tureless bioprosthetic aortic valve in an el-
derly patient.
Case presentation
A 79-year-old gentleman presented with 
worsening breathlessness, New York 
Heart Association class III, 2 years after 
surgical aortic valve replacement with a 
27 mm sutureless 3f Enable bioprosthesis 
alongside coronary artery bypass (left in-
ternal mammary to left anterior descend-
ing). His admission transthoracic and 
transoesophageal echocardiograms re-
vealed a volume-loaded, dilated left ven-
tricle (left ventricular end-diastolic diam-
eter [LVEDD] 67 mm, LV end-systolic di-
ameter [LVESD] 47 mm) with preserved 
ejection fraction (60%). There was a well 
seated aortic bioprosthesis with severe 
paravalvular aortic regurgitation (grade 
+3, with diastolic flow reversal in the tho-
racic aorta; Figure 1A) originating from 
two orifices adjacent to the non- (NCC) 
and left coronary cusp (LCC) (distance 
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between orifices <10 mm; Figure 1B). Computed to-
mography revealed two paraprosthetic defects adja-
cent to each other, with the one closer to the LCC be-
ing larger (8 × 3 mm; Figure 1C-F). The case was dis-
cussed by the local Heart Team. In view of the need 
for redo aortic valve replacement in a patient with a 
patent LIMA-to-LAD graft and moderately high sur-
gical risk (Logistic EuroSCORE 13.6%, EuroSCORE 
II 4.67%, STS 3.6% STS-PROM 24.05%), the deci-
sion was made to proceed to percutaneous paraval-
vular leak closure2 using Amplatzer vascular plugs II 
(AVPII; AGA Medical Corp., Plymouth, Minnesota, 
USA). The procedure was performed under general 
anaesthesia and transoesophageal echo guidance. Us-
ing a right femoral approach, and a multipurpose di-
agnostic catheter, the LCC paravalvular defect was 
crossed with a Storq 0.035’’ wire (Cordis, Johnson 
and Johnson, Miami Lakes, FL, USA) (Figure 2A). 
A 10 mm AVPII device was delivered via a long 6 F 
sheath (Figure 2B, C) and released from its cable as 
the paravalvular leak originating from this orifice di-
minished. However, the second orifice contributed 
to moderate residual paravalvular aortic regurgita-
tion. The decision was therefore made to seal the ad-
jacent defect with a second AVPII, size 8 mm. How-
ever, catheter manipulations in the adjacent NCC ori-
fice appeared to interfere with the stability of the first 
device.
Unfortunately, the first AVPII device had al-
ready been released from its delivery cable. Hence, 
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Figure 1. A: Three-chamber transthoracic echocardiogram pre percutaneous closure of a paravalvular leak (PVL), demonstrating severe 
aortic regurgitation. B: Transoesophageal echo pre percutaneous PVL closure, demonstrating two regurgitant orifices, each 4 mm, adja-
cent to the non-coronary and left coronary cusps. C: Computed tomography (CT) volume reconstruction, transverse double oblique view. 
Green dots highlight the orifices of the two paravalvular defects. D: CT, transverse double oblique plane just below the coronary cusps. 
Yellow arrows highlight the presence of two paraprosthetic defects, the larger adjacent to the left coronary cusp (8 × 3 mm), and the 
smaller adjacent to the non-coronary cusp (6 × 3 mm), in close proximity to first one. E: CT volume reconstruction, coronal oblique view, 
demonstrating the location of the PVL in relation to the 3f Enable valve. F: CT coronal oblique plane with yellow arrow demonstrating 
PVL. LCC – left coronary cusp; NCC – non-coronary cusp; RCC – right coronary cusp.
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PVL crossing with MPA catheter First AVPII 10 mm deployment
AVPII snaring and MPA approaching the
defect to cross through adjacent PVL
Crossing NCC adjacent PVL with long sheath whilst
fist AVPII under traction with Gooseneck snare Second AVPII 8 mm deployment Second AVPII release
Figure 2. Steps demonstrating paravalvular leak (PVL) closure using two Amplatzer vascular plug II (AVPII) devices. The white dotted 
line highlights the position of the first 10 mm AVPII device. See text for further details. MPA – multipurpose catheter; NCC – non-coro-
nary cusp.
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Figure 3. Three-chamber transthoracic 
echocardiogram pre and post percuta-
neous paravalvular leak (PVL) closure.
Pre PVL closure Post PVL closure
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the decision was made to secure it using a gooseneck 
snare (Amplatz GooseNeck snare, Microvena, St. 
Paul, Minnesota, USA) (Figure 2D, E). Left femo-
ral artery access with a 6F sheath was achieved. The 
NCC adjacent defect was crossed with the use of a 
Storq wire under fluoroscopic and transoesopha-
geal echo guidance. Subsequently, the multipurpose 
A catheter and the long 6F sheath were advanced 
through the residual paravalvular defect, while the 
first plug was maintained in place under traction with 
the Gooseneck wire via the right femoral access (Fig-
ure 2E). The second, 8 mm AVPII was delivered suc-
cessfully in close proximity to the first one (Figure 
2F, G) with dramatic reduction of the aortic regur-
gitation from moderate (Figure 3 pre) to trivial (Fig-
ure 3 post).
Discussion
To our knowledge, this is the first case demonstrating 
a successful percutaneous PVL closure after 3f En-
able aortic valve implantation. The risk of reopera-
tion in elderly patients with PVL of sutureless valves 
is high, particularly when their associated comorbidi-
ties are taken into consideration. In current times, an 
increasing number of elderly patients with severe aor-
tic stenosis are treated with sutureless valves (either 
surgically, or using transcatheter aortic valve implan-
tation –TAVI).3,4 It is expected, therefore, that the 
number of high-risk patients with paravalvular leaks 
after sutureless valve implantation will also increase. 
Given the often high reoperation risk or even inop-
erable state of some of these patients, percutaneous 
options should always be considered as an alternative 
when anatomy allows.5
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